Report Detail

Pharma & Healthcare Global Cancer Diagnostics Market Professional Survey Report 2019

  • RnM3812319
  • |
  • 11 October, 2019
  • |
  • Global
  • |
  • 101 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

This report manily covers cancer diagnostics market.Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body.
North America is expected to account for the largest share in the cancer diagnostics market, followed by Europe and Asia. 
The Asian market is slated to grow at the highest CAGR in the coming five years and serves as a revenue pocket for the companies operating in the cancer diagnostics market.

The global Cancer Diagnostics market was valued at 8990 million US$ in 2018 and will reach 23200 million US$ by the end of 2025, growing at a CAGR of 12.6% during 2019-2025.
This report focuses on Cancer Diagnostics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Diagnostics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Cancer Diagnostics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Cancer Diagnostics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Becton, Dickinson and Company
GE Healthcare
Abbott
Roche
Thermo Fisher Scientific
Agilent Technologies
Illumina
Siemens Healthcare
C.R. Bard

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Platform-based
Instrument-based

Segment by Application
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Others


Table of Contents

    Executive Summary

      1 Industry Overview of Cancer Diagnostics

      • 1.1 Definition of Cancer Diagnostics
      • 1.2 Cancer Diagnostics Segment by Type
        • 1.2.1 Global Cancer Diagnostics Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Platform-based
        • 1.2.3 Instrument-based
      • 1.3 Cancer Diagnostics Segment by Applications
        • 1.3.1 Global Cancer Diagnostics Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Breast Cancer
        • 1.3.3 Lung Cancer
        • 1.3.4 Colorectal Cancer
        • 1.3.5 Melanoma
        • 1.3.6 Others
      • 1.4 Global Cancer Diagnostics Overall Market
        • 1.4.1 Global Cancer Diagnostics Revenue (2014-2025)
        • 1.4.2 Global Cancer Diagnostics Production (2014-2025)
        • 1.4.3 North America Cancer Diagnostics Status and Prospect (2014-2025)
        • 1.4.4 Europe Cancer Diagnostics Status and Prospect (2014-2025)
        • 1.4.5 China Cancer Diagnostics Status and Prospect (2014-2025)
        • 1.4.6 Japan Cancer Diagnostics Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Cancer Diagnostics Status and Prospect (2014-2025)
        • 1.4.8 India Cancer Diagnostics Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Cancer Diagnostics
      • 2.3 Manufacturing Process Analysis of Cancer Diagnostics
      • 2.4 Industry Chain Structure of Cancer Diagnostics

      3 Development and Manufacturing Plants Analysis of Cancer Diagnostics

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Cancer Diagnostics Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Cancer Diagnostics
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Cancer Diagnostics Production and Capacity Analysis
      • 4.2 Cancer Diagnostics Revenue Analysis
      • 4.3 Cancer Diagnostics Price Analysis
      • 4.4 Market Concentration Degree

      5 Cancer Diagnostics Regional Market Analysis

      • 5.1 Cancer Diagnostics Production by Regions
        • 5.1.1 Global Cancer Diagnostics Production by Regions
        • 5.1.2 Global Cancer Diagnostics Revenue by Regions
      • 5.2 Cancer Diagnostics Consumption by Regions
      • 5.3 North America Cancer Diagnostics Market Analysis
        • 5.3.1 North America Cancer Diagnostics Production
        • 5.3.2 North America Cancer Diagnostics Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Cancer Diagnostics Import and Export
      • 5.4 Europe Cancer Diagnostics Market Analysis
        • 5.4.1 Europe Cancer Diagnostics Production
        • 5.4.2 Europe Cancer Diagnostics Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Cancer Diagnostics Import and Export
      • 5.5 China Cancer Diagnostics Market Analysis
        • 5.5.1 China Cancer Diagnostics Production
        • 5.5.2 China Cancer Diagnostics Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Cancer Diagnostics Import and Export
      • 5.6 Japan Cancer Diagnostics Market Analysis
        • 5.6.1 Japan Cancer Diagnostics Production
        • 5.6.2 Japan Cancer Diagnostics Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Cancer Diagnostics Import and Export
      • 5.7 Southeast Asia Cancer Diagnostics Market Analysis
        • 5.7.1 Southeast Asia Cancer Diagnostics Production
        • 5.7.2 Southeast Asia Cancer Diagnostics Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Cancer Diagnostics Import and Export
      • 5.8 India Cancer Diagnostics Market Analysis
        • 5.8.1 India Cancer Diagnostics Production
        • 5.8.2 India Cancer Diagnostics Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Cancer Diagnostics Import and Export

      6 Cancer Diagnostics Segment Market Analysis (by Type)

      • 6.1 Global Cancer Diagnostics Production by Type
      • 6.2 Global Cancer Diagnostics Revenue by Type
      • 6.3 Cancer Diagnostics Price by Type

      7 Cancer Diagnostics Segment Market Analysis (by Application)

      • 7.1 Global Cancer Diagnostics Consumption by Application
      • 7.2 Global Cancer Diagnostics Consumption Market Share by Application (2014-2019)

      8 Cancer Diagnostics Major Manufacturers Analysis

      • 8.1 Becton, Dickinson and Company
        • 8.1.1 Becton, Dickinson and Company Cancer Diagnostics Production Sites and Area Served
        • 8.1.2 Becton, Dickinson and Company Product Introduction, Application and Specification
        • 8.1.3 Becton, Dickinson and Company Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 GE Healthcare
        • 8.2.1 GE Healthcare Cancer Diagnostics Production Sites and Area Served
        • 8.2.2 GE Healthcare Product Introduction, Application and Specification
        • 8.2.3 GE Healthcare Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Abbott
        • 8.3.1 Abbott Cancer Diagnostics Production Sites and Area Served
        • 8.3.2 Abbott Product Introduction, Application and Specification
        • 8.3.3 Abbott Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Roche
        • 8.4.1 Roche Cancer Diagnostics Production Sites and Area Served
        • 8.4.2 Roche Product Introduction, Application and Specification
        • 8.4.3 Roche Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Thermo Fisher Scientific
        • 8.5.1 Thermo Fisher Scientific Cancer Diagnostics Production Sites and Area Served
        • 8.5.2 Thermo Fisher Scientific Product Introduction, Application and Specification
        • 8.5.3 Thermo Fisher Scientific Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Agilent Technologies
        • 8.6.1 Agilent Technologies Cancer Diagnostics Production Sites and Area Served
        • 8.6.2 Agilent Technologies Product Introduction, Application and Specification
        • 8.6.3 Agilent Technologies Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Illumina
        • 8.7.1 Illumina Cancer Diagnostics Production Sites and Area Served
        • 8.7.2 Illumina Product Introduction, Application and Specification
        • 8.7.3 Illumina Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Siemens Healthcare
        • 8.8.1 Siemens Healthcare Cancer Diagnostics Production Sites and Area Served
        • 8.8.2 Siemens Healthcare Product Introduction, Application and Specification
        • 8.8.3 Siemens Healthcare Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 C.R. Bard
        • 8.9.1 C.R. Bard Cancer Diagnostics Production Sites and Area Served
        • 8.9.2 C.R. Bard Product Introduction, Application and Specification
        • 8.9.3 C.R. Bard Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served

      9 Development Trend of Analysis of Cancer Diagnostics Market

      • 9.1 Global Cancer Diagnostics Market Trend Analysis
        • 9.1.1 Global Cancer Diagnostics Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Cancer Diagnostics Regional Market Trend
        • 9.2.1 North America Cancer Diagnostics Forecast 2019-2025
        • 9.2.2 Europe Cancer Diagnostics Forecast 2019-2025
        • 9.2.3 China Cancer Diagnostics Forecast 2019-2025
        • 9.2.4 Japan Cancer Diagnostics Forecast 2019-2025
        • 9.2.5 Southeast Asia Cancer Diagnostics Forecast 2019-2025
        • 9.2.6 India Cancer Diagnostics Forecast 2019-2025
      • 9.3 Cancer Diagnostics Market Trend (Product Type)
      • 9.4 Cancer Diagnostics Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Cancer Diagnostics Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Cancer Diagnostics. Industry analysis & Market Report on Cancer Diagnostics is a syndicated market report, published as Global Cancer Diagnostics Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Cancer Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,814.00
        4,221.00
        5,628.00
        3,272.50
        4,908.75
        6,545.00
        541,485.00
        812,227.50
        1,082,970.00
        291,655.00
        437,482.50
        583,310.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report